Enzychem Lifesciences Corporation (KOSDAQ:183490)
990.00
-27.00 (-2.65%)
Mar 25, 2026, 7:48 AM KST
Enzychem Lifesciences Revenue
In the year 2025, Enzychem Lifesciences had annual revenue of 67.75B KRW, down -12.44%. Enzychem Lifesciences had revenue of 14.10B in the quarter ending December 31, 2025, a decrease of -23.87%.
Revenue
67.75B
Revenue Growth
-12.44%
P/S Ratio
1.13
Revenue / Employee
521.16M
Employees
130
Market Cap
76.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 67.75B | -9.63B | -12.44% |
| Dec 31, 2024 | 77.38B | 1.34B | 1.76% |
| Dec 31, 2023 | 76.04B | 49.40B | 185.46% |
| Dec 31, 2022 | 26.64B | 3.66B | 15.94% |
| Dec 31, 2021 | 22.98B | -2.84B | -11.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jeil Pharma Holdings | 657.61B |
| Ildong Holdings | 590.89B |
| HANDOK | 535.14B |
| Dongwha Pharm.Co.,Ltd | 496.39B |
| MYUNGMOON Pharm co.,Ltd | 193.64B |
| Kukje Pharma | 175.50B |
| CKD Bio | 159.93B |
| Yuyu Pharma | 139.51B |